No abstract listed.
Butazolidin plasma concentration and urinary excretion in normal individuals and in patients with rheumatoid spondylitis
Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone
HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED
DRUG INTERACTIONS IN MAN. I. LOWERING EFFECT OF PHENOBARBITAL ON PLASMA LEVELS OF BISHYDROXYCOUMARIN (DICUMAROL) AND DIPHENYLHYDANTOIN (DILANTIN)
Absorption, distribution, & metabolism of 2,2-dichloropropionic acid in relation to phytotoxicity. II. Distribution & metabolic fate of dalapon in plants
Displacement of phenprocoumon (Marcumar) from albumin by sulfonylurea compounds, suramin, and ioglycamic acid
Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters
Some quantitative investigations of the binding to and the displacement of bishydroxycoumarin from human serum albumin
Mechanism for potentiation of warfarin by phenylbutazone. Inhibition of vitamin K-dependent carboxylation and prothrombin synthesis by phenylbutazone in preparations from rat liver
Spectrophotofluorometric evidence of negatively cooperative binding of warfarin and phenylbutazone to human serum albumin
Plasma protein binding displacement interactions--why are they still regarded as clinically important?
Displacement from protein binding of sulphormethoxine by phenylbutazone using in vivo dialysis in rats
An in vitro study of drug displacement interactions: warfarin-salicylate and warfarin-phenylbutazone
Double blind study of the effect of glafenine (Glifanan) on oral anticoagulant therapy with phenprocoumon (Marcumar)
Blood Clotting Disorders
Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.